How long can you live with abdominal metastasis of gastric cancer

How long can a patient live after gastric cancer metastasizes to the abdominal cavity? This is a topic of great concern to many patients and their families. Gastric cancer does not have very obvious symptoms in the early stages. When patients realize that they have gastric cancer, it is already in the late stages, and metastasis is one of the manifestations of late stage gastric cancer. At present, there is no clear answer to the survival time after gastric cancer metastasis, but the following aspects are related to the life cycle of patients with gastric cancer metastasis.

Treatment of abdominal metastasis of gastric cancer

The treatment plan is determined according to the situation of abdominal metastasis. In the past, surgical treatment was not considered once abdominal metastasis occurred. However, in recent years, domestic and foreign studies have shown that for patients with limited peritoneal metastasis (local peritoneal metastasis is defined in the exploration), systemic chemotherapy combined with intraperitoneal hyperthermia perfusion chemotherapy can be considered for further exploration. If the metastatic nodules disappear or the metastatic scars are biopsied again and no cancer cells are found pathologically, radical treatment can be considered. Radical surgical resection has a good effect in some patients.

However, diffuse peritoneal metastasis means extensive metastasis in the abdominal and pelvic cavities, which means that there is no chance for radical surgery. For these patients, the best treatment is intraperitoneal hyperthermia perfusion chemotherapy. If the physical condition allows, combined with systemic chemotherapy, if immunohistochemistry shows (++) or F.IST is positive, HER2 gene testing is recommended. Chemotherapy combined with Herceptin targeted drug therapy is recommended.

Prognosis of peritoneal metastasis of gastric cancer

It varies from person to person and is mainly related to the severity of metastasis, the response to chemotherapy drugs and the overall condition of the body. Some patients receive intraperitoneal hyperthermia perfusion chemotherapy combined with systemic chemotherapy and can survive for 1-3 years or even longer.

Hyperthermic intraperitoneal chemotherapy

Systemic chemotherapy has limited effect on abdominal metastasis, mainly due to the peritoneal plasma barrier effect and low peritoneal blood drug concentration. Based on the difference in stability tolerance between normal cells and normal cells, combined with the anatomical characteristics of the abdomen and the synergistic effect of chemotherapy and hyperthermia, intraperitoneal hyperthermia perfusion chemotherapy can be destroyed by heating the high-concentration mixture. The hot perfusion fluid (42 degrees) and chemotherapy drugs reach the predetermined stability and are infused into the abdominal cavity for continuous heating and circulatory perfusion for 30-50 minutes. Free cancer cells in the peritoneal cavity have a unique therapeutic effect in the treatment of abdominal metastasis, even if micro-metastasis is removed.

The factors that affect the life cycle of gastric cancer patients are as follows:
First, generally, it depends on whether it is discovered and treated early. However, most tumors generally have no symptoms in the early stage, and once discovered, they are in the middle or late stage. If it is a cancer found during a census, it is generally discovered early, and surgical treatment is very helpful to improve the patient's survival rate.
Second, mentality is a very important factor. Patients should not be troubled by the question of how long they can live. Maintaining a calm mood and actively cooperating with surgical treatment will have a positive impact on survival time after surgery.
3. Whether the treatment method is appropriate, whether the surgery is thorough, and whether the treatment measures are timely, to a large extent, affect how long the patient can survive after gastric cancer surgery. According to the patient's cancer pathological stage and physical condition, timely selection of the most appropriate surgical treatment can prolong the postoperative survival time.
Fourth, how long a patient can live with gastric cancer metastasis is also related to the patient's physical function to a certain extent. Only with good physical function and strong immunity can one resist the development of cancer and tolerate various drug treatments. Therefore, it is very important for gastric cancer patients to improve their immune function and enhance their resistance to tumors.
5. Proper care can ensure that patients have excellent treatment conditions and reduce their pain and psychological depression.
Warm Tips: The above is the full introduction of the article, I hope it will be helpful to you. Gastric cancer metastasis indicates that it has reached the late stage of gastric cancer, and the difficulty of treatment will increase a lot. Therefore, everyone should take regular physical examinations, especially pay attention to the examination of the stomach. You should also have a good plan for your usual eating habits and develop good living and eating habits.